ArticleScientific reports2025
Relationship between glucose to lymphocyte ratio and the first peritonitis episode in patients treated with peritoneal dialysis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Development and validation of a nomogram for peritoneal dialysis-associated peritonitis.Renal failure · 2026Article
- Association of the glucose-to-lymphocyte ratio with all-cause and cardiovascular disease mortality in U.S. adults: A population-based cohort study.Clinics (Sao Paulo, Brazil) · 2026Article
- Inflammation, glucose metabolism, and nutritional markers in relation to all-cause and cardiac mortality among initial hemodialysis patients: a multicenter cohort study.Frontiers in nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
This study aimed to investigate the potential relationship between baseline glucose to lymphocyte ratio (GLR) levels and the first episode of peritonitis in patients treated with peritoneal dialysis (PD). A total of 314 patients treated with PD were included and divided into three groups based on GLR tertiles: tertile 1 (GLR ≤ 4.23); tertile 2 (4.23 < GLR ≤ 5.96), and tertile 3 (GLR > 5.96). The relationships between GLR and the first peritonitis episode were analyzed using Kaplan-Meier curves and multivariable Cox regression models. Competitive risk analysis, subgroup and sensitivity analyses were performed to validate the robustness of the findings. During a median follow-up of 27 months, 123 (39.17%) patients developed the first episode of peritonitis. The incidence of the first peritonitis episode increased with the higher GLR tertiles (tertile 1: 32.08%, tertile 2: 37.50%, tertile 3: 48.08%). Kaplan-Meier curves revealed significant differences in the cumulative incidence of the first peritonitis episode among the GLR tertiles (Log-Rank test, P = 0.018). After full adjustment for confounding factors, patients in tertile 3 remained at significantly higher risk for the first episode of peritonitis compared to those in tertile 1 (HR 2.633, 95% CI 1.223-5.668, P = 0.013). Competitive risk models and sensitivity analysis further confirmed this association. Our study suggests that elevated GLR is associated with an increased risk of the first peritonitis episode in patients with PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.